CapWealth Advisors, LLC

Position in ABBV — AbbVie Inc.

CIK 1531809 FRANKLIN, TN

Position in ABBV

as of Jun 30, 2026 · filed Jul 28, 2026 Compact

Position Value

$201,060

-$48,159 QoQ

Shares Held

799

-36.7% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#3,957

of 4,153 holders

Holding Since

Dec 2021

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

CapWealth Advisors, LLC holds $131,948,097 across 6 Drug Manufacturers - General names. ABBV ranks #6 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MRK	Merck & Co., Inc.	273,326	$35,122,391
2	JNJ	Johnson & Johnson	137,077	$34,813,445
3	GILD	Gilead Sciences, Inc.	233,781	$29,535,891
4	AMGN	Amgen Inc	58,570	$21,209,368
5	LLY	ELI LILLY & Co	9,226	$11,065,942
6	ABBV	AbbVie Inc. This page	799	$201,060

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$201,060	799	-36.7%	Shares	Sole	2026-07-28
2024-09-30	$249,219	1,262	+7.9%	Shares	Sole	2024-10-31
2024-06-30	$200,678	1,170	+0.1%	Shares	Sole	2024-08-05
2024-03-31	$212,874	1,169	-58.6%	Shares	Sole	2024-05-03
2023-12-31	$438,100	2,827	+11.2%	Shares	Sole	2024-01-31
2023-09-30	$379,059	2,543	-11.8%	Shares	Sole	2023-11-01
2023-06-30	$388,426	2,883	-2.0%	Shares	Sole	2023-08-07
2023-03-31	$469,025	2,943	-3.3%	Shares	Sole	2023-05-02
2022-12-31	$491,617	3,042	+15.1%	Shares	Sole	2023-02-01
2022-09-30	$354,582	2,642	-10.4%	Shares	Sole	2022-11-02
2022-06-30	$451,822	2,950	+10.6%	Shares	Sole	2022-08-05
2022-03-31	$432,347	2,667	0.0%	Shares	Sole	2022-05-04
2021-12-31	$361,111	2,667	—	Shares	Sole	2022-02-10
No filing history on record for this holder in this stock.